Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12012601 Combination therapy with liposomal antisense oligonucleotides

Patent 12012601 was granted and assigned to Bio-Path Holdings on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Bio-Path Holdings
Bio-Path Holdings
0
Date Filed
January 15, 2021
0
Date of Patent
June 18, 2024
0
Patent Applicant
Bio-Path Holdings
Bio-Path Holdings
0
Patent Application Number
17150151
0
Patent Citations
‌
US Patent 7285288 Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
0
‌
US Patent 7309692 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
0
‌
US Patent 7425545 Modulation of C-reactive protein expression
0
‌
US Patent 7704962 Small oligonucleotides with anti-tumor activity
0
‌
US Patent 7754872 Liposomal phosphodiester, phophorothioate, and p-ethoxy oligonucleotides
0
‌
US Patent 7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1
0
‌
US Patent 9744187 p-Ethoxy nucleic acids for liposomal formulation
0
‌
US Patent 10087464 Compositions and methods for delivering nucleic acid to a cell
0
‌
US Patent 10335428 P-ethoxy nucleic acids for liposomal formulation
0
‌
US Patent 10898506 P-ethoxy nucleic acids for liposomal formulation
0
•••
Patent Inventor Names
Ana Tari Ashizawa
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12012601
0
Patent Primary Examiner
‌
Sean McGarry
0

Find more entities like US Patent 12012601 Combination therapy with liposomal antisense oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo